Investor Type
Anne Valat, Principal Scientist at Bolden Therapeutics.
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
obfuscated obfuscation | Bolden Therapeutics | National Institute on Aging | Grant - Bolden Therapeutics | obfuscated obfuscation | |
obfuscated obfuscation | Bolden Therapeutics | National Institute on Aging | Grant - Bolden Therapeutics | obfuscated obfuscation |